Literature DB >> 468067

Chronic persistent hepatitis: hepatitis B virus markers and histological follow-up.

R G Chadwick, J Galizzi, J Heathcote, T Lyssiotis, B J Cohen, P J Scheuer, S Sherlock.   

Abstract

Twenty-six untreated patients with chronic persistent hepatitis were followed prospectively for one to 17 years (mean 5.6 years). The patients developed no clinical features of chronic liver disease. Raised serum transaminase levels were usually, but not consistently, the only biochemical abnormality; gamma globulin values were normal. Serum markers of past or present hepatitis B infection were found initially in 14 patients: another two developed markers during their follow-up. Nine patients progressed to a mild or moderate chronic active hepatitis as shown by serial needle liver biopsies but there was no evidence of cirrhosis. This progression was not associated with any clinical or biochemical deterioration. Seven of these patients had presented with insidious symptoms, seven had serum markers of hepatitis B infection, and the four who were HBsAg positive had relatively lower serum HBsAg concentrations than did those patients who continued with chronic persistent hepatitis.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 468067      PMCID: PMC1412438          DOI: 10.1136/gut.20.5.372

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  17 in total

1.  Fluorescent antibody studies with agents of varicella and herpes zoster propagated in vitro.

Authors:  T H WELLER; A H COONS
Journal:  Proc Soc Exp Biol Med       Date:  1954 Aug-Sep

2.  Prognosis of chronic persistent hepatitis.

Authors:  M D Becker; A Baptista; P J Scheuer; S Sherlock
Journal:  Lancet       Date:  1970-01-10       Impact factor: 79.321

3.  Proceedings: Studies on carriers of Australia antibody.

Authors:  E D Fairclough; G Slavin; E Willis; T P Cleghorn; M Denman; A J Levi
Journal:  Gut       Date:  1974-04       Impact factor: 23.059

4.  Prevalence of hepatitis B e antigen and its antibody as detected by radioimmunoassays.

Authors:  I K Mushahwar; L R Overby; G Frosner; F Deinhardt; C M Ling
Journal:  J Med Virol       Date:  1978       Impact factor: 2.327

5.  Acute and chronic hepatitis revisited. Review by an international group.

Authors: 
Journal:  Lancet       Date:  1977-10-29       Impact factor: 79.321

6.  Application of a screening test for antibody the hepatitis B core antigen.

Authors:  B J Cohen; Y E Cossart
Journal:  J Clin Pathol       Date:  1977-08       Impact factor: 3.411

7.  Correlation between titer of antibody to hepatitis B core antigen and presence of viral antigens in the liver.

Authors:  M Kojima; K Udo; Y Takahashi; H Yoshizawa; F Tsuda; Y Itoh; Y Miyakawa; M Mayumi
Journal:  Gastroenterology       Date:  1977-10       Impact factor: 22.682

8.  Relationship of hepatitis-associated antigen (H.A.A.) to acute and chronic liver injury.

Authors:  F J Dudley; R A Fox; S Sherlock
Journal:  Lancet       Date:  1971-07-03       Impact factor: 79.321

9.  Detection of e antigen and antibody: correlations with hapatitis B surface and hepatitis B core antigens, liver disease, and outcome in hepatitis B infections.

Authors:  C G Trepo; L O Magnius; R A Schaefer; A M Prince
Journal:  Gastroenterology       Date:  1976-11       Impact factor: 22.682

10.  Chronic hepatitis: a problem for the pathologist.

Authors:  P J Scheuer
Journal:  Histopathology       Date:  1977-01       Impact factor: 5.087

View more
  8 in total

1.  Value of liver biopsy prior to interferon therapy for chronic viral hepatitis.

Authors:  T Heintges; L Mohr; F Hensel; W Petry; F Borchard; D Häussinger; C Niederau
Journal:  Dig Dis Sci       Date:  1998-07       Impact factor: 3.199

Review 2.  Corticosteroids in liver disease: possible mechanisms of action, pharmacology, and rational use.

Authors:  A R Tanner; L W Powell
Journal:  Gut       Date:  1979-12       Impact factor: 23.059

Review 3.  Chronic hepatitis: a review.

Authors:  R A Bradbear
Journal:  J R Soc Med       Date:  1985-05       Impact factor: 5.344

Review 4.  Natural history of the HBsAg carrier.

Authors:  M G Anderson; I M Murray-Lyon
Journal:  Gut       Date:  1985-08       Impact factor: 23.059

Review 5.  Interferon in the management of chronic hepatitis B.

Authors:  R P Perrillo
Journal:  Dig Dis Sci       Date:  1993-04       Impact factor: 3.199

6.  The course of chronic persistent hepatitis.

Authors:  Y Arthurs; G D Doyle; J F Fielding
Journal:  Ir J Med Sci       Date:  1982-03       Impact factor: 1.568

7.  The effects of drug abuse on the natural history and progression of chronic active and chronic persistent hepatitis.

Authors:  Y Arthurs; G D Doyle; J F Fielding
Journal:  Ir J Med Sci       Date:  1981-04       Impact factor: 1.568

8.  A study on the relationship between the prognosis of chronic active hepatitis and the HBV associated antigen/antibody systems.

Authors:  Y Kosaka; Y Tameda; Y Okuda; K Takase; H Sawa; H Takezawa
Journal:  Gastroenterol Jpn       Date:  1981-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.